Advertisement
Original Contributions| Volume 43, ISSUE 4, P553-560, October 2012

Diagnostic Performance of Initial Salivary Alpha-Amylase Activity for Acute Myocardial Infarction in Patients with Acute Chest Pain

Published:November 07, 2011DOI:https://doi.org/10.1016/j.jemermed.2011.06.040

      Abstract

      Background

      To rule out acute myocardial infarction (AMI) in chest pain patients constitutes a diagnostic challenge to emergency department (ED) physicians.

      Study Objectives

      To evaluate the diagnostic value of measuring salivary alpha-amylase (sAA) activity for detecting AMI in patients presenting to the ED with acute chest pain.

      Methods

      sAA activity was measured in a prospective cohort of 473 consecutive adult patients within 4 h of onset of chest pain. Comparisons were made between patients with a final diagnosis of AMI and those with non-AMI. Univariate analysis and multiple logistic regression model were used to identify independent clinical predictors of AMI.

      Results

      Initial sAA activity in the AMI group (n = 85; 266 ± 127.6 U/mL) was significantly higher than in the non-AMI group (n = 388; 130 ± 92.8 U/mL, p < 0.001). sAA activity levels were also significantly higher in patients with ST elevation AMI (n = 53) compared to in those with non-ST elevation AMI (n = 32) (300 ± 141.1 vs. 210 ± 74.1 U/mL, p < 0.001). The area under the receiver operating characteristic curve of sAA activity for predicting AMI in patients with acute chest pain was 0.826 (95% confidence interval [CI] 0.782–0.869), with diagnostic odds ratio 10.87 (95% CI 6.16–19.18). With a best cutoff value of 197.7 U/mL, the sAA activity revealed moderate sensitivity and specificity as an independent predictor of AMI (78.8% and 74.5%).

      Conclusions

      High initial sAA activity is an independent predictor of AMI in patients presenting to the ED with chest pain.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Emergency Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Hoenig M.R.
        • Aroney C.N.
        • Scott I.A.
        Early invasive versus conservative strategies for unstable angina and non-ST elevation myocardial infarction in the stent era.
        Cochrane Database Syst Rev. 2010; : CD004815
        • Jesse R.L.
        • Kontos M.C.
        Evaluation of chest pain in the emergency department.
        Curr Probl Cardiol. 1997; 22: 149-236
        • Tatum J.L.
        • Jesse R.L.
        • Kontos M.C.
        • et al.
        Comprehensive strategy for the evaluation and triage of the chest pain patient.
        Ann Emerg Med. 1997; 29: 116-125
        • Puleo P.R.
        • Meyer D.
        • Wathen C.
        • et al.
        Use of a rapid assay of subforms of creatine kinase MB to diagnose or rule out acute myocardial infarction.
        N Engl J Med. 1994; 331: 561-566
      1. Wu A.H.B. Cardiac markers (pathology and laboratory medicine). 2nd edn. Humana Press, Totowa, NJ2003
        • Young G.P.
        • Green T.R.
        The role of single ECG, creatinine kinase, and CKMB in diagnosing patients with acute chest pain.
        Am J Emerg Med. 1993; 11: 444-449
        • Kaufman E.
        • Lamster I.B.
        The diagnostic applications of saliva—a review.
        Crit Rev Oral Biol Med. 2002; 13: 197-212
        • Floriano P.N.
        • Christodoulides N.
        • Miller C.S.
        • et al.
        Use of saliva-based nano-biochip tests for acute myocardial infarction at the point of care: a feasibility study.
        Clin Chem. 2009; 55: 1530-1538
        • Dantzer R.
        • Kalin N.
        Salivary biomarkers of stress: cortisol and alpha-amylase.
        Psychoneuroendocrinology. 2009; 34: 1
        • Malliani A.
        • Schwartz P.
        • Zanchetti A.
        A sympathetic reflex elicited by experimental coronary occlusion.
        Am J Physiol. 1969; 217: 703-709
        • Nater U.M.
        • Rohleder N.
        Salivary alpha-amylase as a non-invasive biomarker for the sympathetic nervous system: current state of research.
        Psychoneuroendocrinology. 2009; 34: 486-496
        • Thygesen K.
        • Alpert J.S.
        • White H.D.
        • et al.
        • Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction
        Universal definition of myocardial infarction.
        Circulation. 2007; 116: 2634-2653
        • Karlsberg R.P.
        • Cryer P.E.
        • Roberts R.
        Serial plasma catecholamine response early in the course of clinical acute myocardial infarction: relationship to infarct extent and mortality.
        Am Heart J. 1981; 102: 24-29
        • Haft J.I.
        • Fani K.
        Intravascular platelet aggregation in the heart induced by stress.
        Circulation. 1973; 47: 353-358
        • Corr P.B.
        • Witkowski F.X.
        • Sobel B.E.
        Mechanisms contributing to malignant dysrhythmias induced by ischemia in the cat.
        J Clin Invest. 1978; 61: 109-119
        • Mueller H.
        • Ayres S.M.
        • Religa A.
        • Evans R.G.
        Propranolol in the treatment of acute myocardial infarction: effect on myocardial oxygenation and hemodynamics.
        Circulation. 1974; 49: 1078-1087
        • Snow P.J.
        Effect of propranolol in myocardial infarction.
        Lancet. 1965; 2: 551-553
        • Speirs R.L.
        • Herring J.
        • Cooper W.D.
        • Hardy C.C.
        • Hind C.R.
        The influence of sympathetic activity and isoprenaline on the secretion of amylase from the human parotid gland.
        Arch Oral Biol. 1974; 19: 747-752
        • Nederfors T.
        • Dahlof C.
        Effects of the beta-adrenoceptor antagonists atenolol and propranolol on human whole saliva flow rate and composition.
        Arch Oral Biol. 1992; 37: 579-584
        • Chatterton Jr., R.T.
        • Vogelsong K.M.
        • Lu Y.C.
        • Ellman A.B.
        • Hudgens G.A.
        Salivary alpha-amylase as a measure of endogenous adrenergic activity.
        Clin Physiol. 1996; 16: 433-448
        • Bosch J.A.
        • de Geus E.J.C.
        • Veerman E.C.I.
        • Hoogstraten J.
        • Nieuw Amerongen A.V.
        Innate secretory immunity in response to laboratory stressors that evoke distinct patterns of cardiac autonomic activity.
        Psychosom Med. 2003; 65: 245-258
        • Nater U.M.
        • La Marca R.
        • Florin L.
        • et al.
        Stress-induced changes in human salivary alpha-amylase activity–associations with adrenergic activity.
        Psychoneuroendocrinology. 2006; 31: 49-58
        • DeCaro J.A.
        Methodological considerations in the use of salivary alpha-amylase as a stress marker in field research.
        Am J Hum Biol. 2008; 20: 617-619
        • Sharma A.D.
        • Corr P.B.
        Adrenergic factors in arrhythmogenesis in the ischemic and reperfused myocardium.
        Eur Heart J. 1983; 4: 79-90
        • Wollenberger A.
        • Shahab L.
        Anoxia-induced release of noradrenaline from the isolated perfused heart.
        Nature. 1965; 207: 88-89
        • Zipes D.P.
        Influence of myocardial ischemia and infarction on autonomic innervation of heart.
        Circulation. 1990; 82: 1095-1105
        • Adgey A.A.
        • Geddes J.S.
        • Mulholland H.C.
        • Keegan D.A.
        • Pantridge J.F.
        Incidence, significance, and management of early bradyarrhythmia complicating acute myocardial infarction.
        Lancet. 1968; 2: 1097-1101
        • Pantridge J.F.
        • Webb S.W.
        • Adgey A.A.
        Arrhythmias in the first hours of acute myocardial infarction.
        Prog Cardiovasc Dis. 1981; 23: 265-278
        • Graham L.N.
        • Smith P.A.
        • Huggett R.J.
        • Stoker J.B.
        • Mackintosh A.F.
        • Mary D.A.
        Sympathetic drive in anterior and inferior uncomplicated acute myocardial infarction.
        Circulation. 2004; 109: 2285-2289
        • Yamaguchi M.
        • Kanemori T.
        • Kanemaru M.
        • Takai N.
        • Mizuno Y.
        • Yoshida H.
        Performance evaluation of salivary amylase activity monitor.
        Biosens Bioelectron. 2004; 20: 491-497
        • Rohleder N.
        • Nater U.M.
        Determinants of salivary alpha-amylase in humans and methodological considerations.
        Psychoneuroendocrinology. 2009; 34: 469-485
        • Nater U.M.
        • Rohleder N.
        • Schlotz W.
        • Ehlert U.
        • Kirschbaum C.
        Determinants of the diurnal course of salivary alpha-amylase.
        Psychoneuroendocrinology. 2007; 32: 392-401
        • Gerszten R.E.
        • Wang T.J.
        The search for new cardiovascular biomarkers.
        Nature. 2008; 451: 949-952